New painkiller shows promise for post-surgery relief
NCT ID NCT05509868
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new pain medication called PBK_L1704 in 182 people who had foot surgery (bunionectomy) in South Korea. The goal was to see if it relieves moderate to severe pain better than a placebo over 48 hours. Participants received either the drug or a placebo, and pain levels were measured using a standard 0-10 scale.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Seoul Asan medical Center
Seoul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Swiss launch national pain registry to uncover how treatments really work
- Study investigates whether more nerve blocks mean better recovery for polytrauma patients
- Machine learning and cuddles: a new approach to pain in premature infants
- Which additive works best for pain control in brain surgery?
- Brain chemical may boost pain relief learned by observation
- Nerve block may cut opioid use after neck surgery